如何治疗Müller-Weiss疾病:关于治疗算法的系统性审查
Michele Busana1, Sérgio Soares2, Riccardo Garibaldi1
1Department of Orthopaedic Surgery and Traumatology, HFR Fribourg - Cantonal Hospital, Chemin des Pensionnats 2-6, 1752 Villars-sur-Glâne, Switzerland.
Orthopaedics & traumatology, surgery & research : OTSR
|November 22, 2025
概括
穆勒-斯病 (MWD) 管理需要量身定制的方法. 本综述突出显示,托罗骨形关节切除术是MWD的高效治疗方法,尤其是在后期阶段.
科学领域:
- 整形外科 整形外科 整形外科
- 足部医学是一门专业.
- 放射学 放射学是一门学科.
背景情况:
- 穆勒-斯病 (MWD) 是一种退行性疾病,影响船骨和骨关节.
- 它会导致硬化,变形和 navicular 骨的崩.
- 目前对MWD的理解和管理提出了挑战,需要更新治疗策略.
研究的目的:
- 系统地审查和综合对穆勒-斯病 (MWD) 的治疗结果.
- 建立基于MWD的放射和临床阶段的治疗算法.
- 确定当前MWD理解和管理的局限性和挑战.
主要方法:
- 在2023年9月之前,对研究进行符合PRISMA 2020标准的系统审查.
- 在Pubmed和Google Scholar上使用关键字"Müller-Weiss"或"Mueller-Weiss"进行的搜索.
- 分析了25个符合条件的出版物,使用AOFAS评分评估结果.
主要成果:
- 分析了一系列的治疗方法,包括非手术,节节关节和融合手术.
- 关节切除是主要的治疗方法,在80%的研究中出现.
- 塔洛 - 航海器 - 形关节切除是Maceira的III-V阶段最常见的融合技术.
结论:
- 肌肉疾病需要个性化的管理策略.
- 早期诊断,准确的评估和适当的治疗对于MWD至关重要.
- 虽然没有黄金标准的存在,但talo-navicular-cuneiform关节切除显示出明显的承诺,用于纠正形和缓解MWD的症状.
相关概念视频
01:27Open Angle Glaucoma: Treatment
938
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
938
01:28Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
01:22Mitral Valve Prolapse II: Assessment and Management
389
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
389
01:25Mitral Regurgitation III: Medical Management
258
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
258
01:26Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301